Related Experiment Videos
[Hemangioblastomas of central nervous system]
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|February 13, 2004
Summary
Central nervous system hemangioblastomas are rare, benign tumors. Surgical removal is the primary treatment, with radiosurgery for Hippel-Lindau disease, but bleeding and recurrence remain concerns.
Area of Science:
- Neurology
- Oncology
- Neurosurgery
Context:
- Hemangioblastomas are benign, vascular tumors of the central nervous system.
- They most commonly occur in the cerebellum but rarely appear supratentorially.
- Their histogenesis remains unclear, and they can be sporadic or part of Hippel-Lindau syndrome.
Purpose:
- To provide a comprehensive overview of central nervous system hemangioblastomas.
- To discuss diagnostic modalities, treatment options, and potential complications.
Summary:
- Magnetic resonance imaging (MRI) is the definitive diagnostic tool.
- Surgical resection is the mainstay of treatment for sporadic cases.
- Radiosurgery is preferred for Hippel-Lindau disease patients.
- Endovascular embolization can reduce surgical bleeding.
- Recurrence is linked to incomplete resection; chemotherapy is ineffective.
Impact:
- Highlights the rarity and diagnostic challenges of supratentorial hemangioblastomas.
- Emphasizes the importance of multidisciplinary management for optimal patient outcomes.
- Informs clinical practice regarding treatment selection and complication avoidance.